Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Montalban, C.
Right arrow Articles by Bellas, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Montalban, C.
Right arrow Articles by Bellas, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 8:S37-S39, 1997
© 1997 European Society for Medical Oncology

Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: Follow-up together with sequential molecular studies

C. Montalban1, A. Manzanal2, D. Boixeda3, C. Redondo2, I. Alvarez2, J. L. Calleja1 and C. Bellas2

1 Department of Internal Medicine, Hospital Ramon y Cajal, Universidad de Alcalá Madrid, Spain
2 Department of Pathology, Hospital Ramon y Cajal, Universidad de Alcalá Madrid, Spain
3 Department of Gastroenterology, Hospital Ramon y Cajal, Universidad de Alcalá Madrid, Spain

Correspondence to: Dr. C. Montalban Department of Internal Medicine Hospital Ramon y Cajal Carretera de Colmenar Km 9 Madrid 28034, Spain

Background Helicobacter pylori infection is associated with low-grade gastric MALT lymphoma, and available data support that the eradication of the H. pylori can cause histological regression of the lymphoma.

Patients and methods Nine patients with low-grade gastric MALT lymphoma were treated with amoxicillin, metronidazole, and omeprazole for 14 days in a prospective study. Patients were followed up with sequential endoscopy, mapping gastric biopsies, and molecular studies with PCR amplification of the IgH gene in order to assess the response to H. pylori eradication and the evolution of the histological and molecular responses.

Results H. pylori was eradicated in all patients and reinfections were not demonstrated. After H. pylori eradication treatment, the lymphoma regressed both endoscopically and histologically in eight of the nine patients (88.8%). In four of the eight histologically cured patients, no clonal band was detected by PCR; in the remaining four patients; PCR identified a clonal band, which disappeared in all patients after a mean of 12 ± 4 months. No clonal band was detected by the PCR analysis in any of the eight patients with histological regression after a median of 7 ± 6 months (range 1–20). The seven followed-up patients have a persistent clinical and histological remission after a median of 14 ± 5 months.

Conclusions (1) Low-grade gastric MALT lymphoma can be histologically cured with eradication therapy for H. pylori. (2) After histological regression, PCR amplification of the IgH gene can identify an eventually persisting clonal population. (3) Sequential histological and molecular studies are essential for the assessment of the evolution of the lymphoma. (4) The clonal population tends to disappear, but its disappearance may be delayed for months. (5) Patients with histological regression but with a persistent clonal band should not be treated unless the lymphoma can be histologically demonstrated. All these observations suggest that gastric lymphoma can be effectively cured, but the ultimate fate of these patients is unknown until long-term follow-up studies are available.

gastric lymphoma, Helicobactor pylori, lymphoma, MALT


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.